CN117883507A - A Chinese medicine formula for indirectly reversing diabetes and its preparation method - Google Patents
A Chinese medicine formula for indirectly reversing diabetes and its preparation method Download PDFInfo
- Publication number
- CN117883507A CN117883507A CN202410249134.0A CN202410249134A CN117883507A CN 117883507 A CN117883507 A CN 117883507A CN 202410249134 A CN202410249134 A CN 202410249134A CN 117883507 A CN117883507 A CN 117883507A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine formula
- indirectly
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims description 6
- 241000893536 Epimedium Species 0.000 claims abstract description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 14
- 235000018905 epimedium Nutrition 0.000 claims abstract description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 9
- 235000011477 liquorice Nutrition 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 7
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000006187 pill Substances 0.000 claims description 14
- 241000675108 Citrus tangerina Species 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 7
- 235000017803 cinnamon Nutrition 0.000 claims description 7
- 235000012907 honey Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 230000005484 gravity Effects 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 2
- 229940100688 oral solution Drugs 0.000 claims description 2
- -1 oral solution Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 4
- 235000003642 hunger Nutrition 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 241000723347 Cinnamomum Species 0.000 description 3
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000132004 Symphyotrichum cordifolium Species 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010017788 Gastric haemorrhage Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000008386 key pathological change Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域Technical Field
本发明属于中药领域,特别涉及到了一种间接性逆转糖尿病的中药配方。The invention belongs to the field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine formula for indirectly reversing diabetes.
背景技术Background technique
现代药理学实验及临床试验研究表明,适度饥饿可作为主要或辅助手段对糖尿病产生疗效。在临床实践中发现,超重肥胖者“阴常有余”,适度饥饿后多出现肢体冷、不欲饮水、乏力、舌苔增厚、面色黄白等阳气不足、痰湿内泛表现,因此,亟待从中医方剂学和西医药理学的角度出发,对糖尿病者适度饥饿控制体重的副作用进行解决。Modern pharmacological experiments and clinical trials have shown that moderate hunger can be used as a primary or auxiliary means to produce therapeutic effects on diabetes. In clinical practice, it is found that overweight and obese people often have "excess yin". After moderate hunger, they often experience cold limbs, no desire to drink water, fatigue, thick tongue coating, yellow and white complexion, and other symptoms of insufficient yang and phlegm and dampness. Therefore, it is urgent to solve the side effects of moderate hunger in diabetic patients to control their weight from the perspective of traditional Chinese medicine and Western medicine pharmacology.
发明内容Summary of the invention
本发明的目的在于提供一种间接性逆转糖尿病的中药配方,该中药配方对适度饥饿所伴随的副反应有明显的缓解作用,使患者能坚持适度饥饿,逆转糖尿病。The purpose of the present invention is to provide a Chinese medicine formula for indirectly reversing diabetes. The Chinese medicine formula has a significant alleviating effect on the side effects associated with moderate hunger, so that patients can persist in moderate hunger and reverse diabetes.
为了实现上述目的,本发明的技术方案如下。In order to achieve the above object, the technical solution of the present invention is as follows.
一种间接性逆转糖尿病的中药配方,其特征在于,以质量份数计,该中药配方的原料包括有:桂枝5-30份、淫羊藿5-30份、巴戟天5-30份、陈皮5-25份、甘草3-15份。A Chinese medicine formula for indirectly reversing diabetes, characterized in that, measured by weight, the raw materials of the Chinese medicine formula include: 5-30 parts of cassia twig, 5-30 parts of epimedium, 5-30 parts of Morinda officinalis, 5-25 parts of tangerine peel, and 3-15 parts of liquorice.
“阳气不足、痰浊内泛”是适度饥饿逆转糖尿病过程的病理变化关键,所以“温阳化浊”是重点。纵观该中药配方全方,契合“病痰饮者,当以温药和之”和逆转糖尿病过程中的病机关键。"Insufficient Yang Qi and phlegm and turbidity" are the key pathological changes in the process of moderate hunger reversing diabetes, so "warming Yang and removing turbidity" is the key. Looking at the whole Chinese medicine formula, it is consistent with "those with phlegm and fluid should be treated with warm medicine" and the key pathological mechanism in the process of reversing diabetes.
桂枝味辛,性温,归心、肺、膀胱经,可以温阳化气利水,为君药;淫羊藿味辛,性温,归肝、肾经,能够补肾助阳;巴戟天,味辛,性微温,归肾经,可以补肾助阳、化湿,共为臣药;陈皮性甘,味温,可以健脾,燥湿化痰,为佐药;甘草味甘,性平,可以补脾益气、缓急止饿,可以调和诸药,是为使药。Cinnamon twig is pungent in taste and warm in nature. It enters the heart, lung, and bladder meridians. It can warm the yang, transform qi and promote diuresis, and is the main medicine; Epimedium is pungent in taste and warm in nature. It enters the liver and kidney meridians. It can tonify the kidney and assist yang; Morinda officinalis is pungent in taste and slightly warm in nature. It enters the kidney meridian. It can tonify the kidney and assist yang, and eliminate dampness. They are all minister medicines; Tangerine peel is sweet in nature and warm in taste. It can strengthen the spleen, dry dampness and resolve phlegm. It is an adjuvant medicine; Licorice is sweet in taste and neutral in nature. It can tonify the spleen and replenish qi, relieve urgency and stop hunger, and can harmonize all medicines. It is the guiding medicine.
进一步的,该中药配方包括有:桂枝10份、淫羊藿10份、巴戟天10份、陈皮10份、甘草10份。Furthermore, the Chinese medicine formula includes: 10 parts of cinnamon twig, 10 parts of epimedium, 10 parts of Morinda officinalis, 10 parts of tangerine peel, and 10 parts of liquorice.
进一步的,该中药配方包括有:桂枝5份、淫羊藿5份、巴戟天5份、陈皮10份、甘草10份。Furthermore, the Chinese medicine formula includes: 5 parts of cinnamon twig, 5 parts of epimedium, 5 parts of Morinda officinalis, 10 parts of tangerine peel, and 10 parts of liquorice.
进一步的,桂枝为炒桂枝,所述淫羊藿为心叶淫羊藿,所述巴戟天为盐巴戟天,所述陈皮为陈橘皮,所述甘草为胀果甘草。Furthermore, the cassia twig is stir-fried cassia twig, the epimedium is epimedium cordifolia, the Morinda officinalis is salt Morinda officinalis, the tangerine peel is tangerine peel, and the licorice is licorice root.
进一步的,该中药配方为散剂或口服液或片剂或水丸或蜜丸或胶囊。Furthermore, the Chinese medicine formula is in the form of powder, oral liquid, tablet, water pill, honey pill or capsule.
一种逆转糖尿病的中药制备方法,其特征在于,该制备方法包括有:A method for preparing a traditional Chinese medicine for reversing diabetes, characterized in that the preparation method comprises:
将所述中药配方的原料分开或合并加水煎煮两次;Separate or combine the raw materials of the Chinese medicine formula and boil them twice with water;
第一次加水5-10倍量,煮沸1.5-3小时,收集挥发油;Add 5-10 times the amount of water for the first time, boil for 1.5-3 hours, and collect the volatile oil;
第二次加水4-8倍量,煮沸0.5-1.5小时;Add 4-8 times the amount of water for the second time and boil for 0.5-1.5 hours;
合并煎液,进行过滤,并将滤液置于60℃温度下,浓缩形成为比重为1.10-1.35的浓缩液;The decoctions are combined, filtered, and the filtrate is placed at 60° C. and concentrated to form a concentrated solution with a specific gravity of 1.10-1.35;
浓缩液加水稀释,并静置24小时,再取上清液过300-400目滤网,再次浓缩,然后制成散剂或口服液或片剂或水丸或蜜丸或胶囊。The concentrate is diluted with water and allowed to stand for 24 hours, and the supernatant is filtered through a 300-400 mesh filter, concentrated again, and then made into powder, oral solution, tablets, water pills, honey pills or capsules.
在本发明中,本发明的有益效果在于,可以明显缓解禁食过程中,因适度饥饿所产生的副反应,提高患者的依从性,使患者能坚持适度饥饿,逆转糖尿病。In the present invention, the beneficial effect of the present invention is that it can significantly alleviate the side effects caused by moderate hunger during fasting, improve the compliance of patients, enable patients to adhere to moderate hunger, and reverse diabetes.
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
本实施方式提供一种间接性逆转糖尿病的中药配方的第一实施例,以质量份数计,该中药配方包括有:炒桂枝10份、心叶淫羊藿10份、盐巴戟天10份、陈橘皮10份、胀果甘草10份。The present embodiment provides a first example of a traditional Chinese medicine formula for indirectly reversing diabetes. Calculated by weight, the traditional Chinese medicine formula includes: 10 parts of stir-fried cassia twigs, 10 parts of heart-leaf epimedium, 10 parts of salt-leaved Morinda officinalis, 10 parts of old tangerine peel, and 10 parts of inflated fruit liquorice.
在本实施例中,该中药配方为散剂或口服液或片剂或水丸或蜜丸或胶囊。In this embodiment, the Chinese medicine formula is in the form of powder, oral liquid, tablet, water pill, honey pill or capsule.
本实施方式提供一种间接性逆转糖尿病的中药配方的第二实施例,以质量份数计,该中药配方包括有:炒桂枝5份、心叶淫羊藿5份、盐巴戟天5份、陈橘皮10份、胀果甘草10份。The present embodiment provides a second example of a traditional Chinese medicine formula for indirectly reversing diabetes. The traditional Chinese medicine formula includes, by weight: 5 parts of stir-fried cassia twig, 5 parts of heart-leaf epimedium, 5 parts of salt-leaved Morinda officinalis, 10 parts of old tangerine peel, and 10 parts of inflated fruit liquorice.
在本实施例中,该中药配方为散剂或口服液或片剂或水丸或蜜丸或胶囊。In this embodiment, the Chinese medicine formula is in the form of powder, oral liquid, tablet, water pill, honey pill or capsule.
本实施方式还提供一种逆转糖尿病的中药制备方法,该制备方法包括有:This embodiment also provides a method for preparing a traditional Chinese medicine for reversing diabetes, the preparation method comprising:
将所述中药配方的原料分开或合并加水煎煮两次;Separate or combine the raw materials of the Chinese medicine formula and boil them twice with water;
第一次加水5-10倍量,煮沸1.5-3小时,收集挥发油;Add 5-10 times the amount of water for the first time, boil for 1.5-3 hours, and collect the volatile oil;
第二次加水4-8倍量,煮沸0.5-1.5小时;Add 4-8 times the amount of water for the second time and boil for 0.5-1.5 hours;
合并煎液,进行过滤,并将滤液置于60℃温度下,浓缩形成为比重为1.10-1.35的浓缩液;The decoctions are combined, filtered, and the filtrate is placed at 60° C. and concentrated to form a concentrated solution with a specific gravity of 1.10-1.35;
浓缩液加水稀释,并静置24小时,再取上清液过300-400目滤网,再次浓缩;The concentrate was diluted with water and allowed to stand for 24 hours, and the supernatant was filtered through a 300-400 mesh filter and concentrated again;
然后加适量赋形剂,喷雾干燥成颗粒,并分装成小袋,即得散剂;或者按常规制剂工艺制成口服液或片剂或水丸或蜜丸或胶囊。Then add appropriate amount of excipients, spray dry into granules, and pack into small bags to obtain powder; or make into oral liquid, tablets, water pills, honey pills or capsules according to conventional preparation technology.
该中药配方治疗2型糖尿病患者时,在临床上观察了34例为期7天适度饥饿的患者,均为2型糖尿病患者;34例患者均坚持适度饥饿,逆转糖尿病,对所有患者的临床疗效进行评估并随访6月;适度饥饿期间服用本制剂后饥饿感、畏寒肢冷、疲倦乏力、头昏闷等症状明显下降,糖化血红蛋白在禁食后、随访3月和随访6月均显著降低;结果表明本药物对适度饥饿所伴随的副反应有明显的缓解作用,使患者能坚持适度饥饿,逆转糖尿病,并能减轻体重,使用过程中未见低血糖反应及其他不良反应。When this Chinese medicine formula was used to treat patients with type 2 diabetes, 34 patients who were moderately hungry for 7 days were clinically observed, all of whom were type 2 diabetes patients; all 34 patients persisted in moderate hunger and reversed diabetes, and the clinical efficacy of all patients was evaluated and followed up for 6 months; after taking this preparation during the moderate hunger period, symptoms such as hunger, chills and cold limbs, fatigue, dizziness and stuffiness were significantly reduced, and glycosylated hemoglobin was significantly reduced after fasting, 3 months of follow-up, and 6 months of follow-up; the results showed that this drug has a significant alleviating effect on the side effects associated with moderate hunger, allowing patients to persist in moderate hunger, reverse diabetes, and lose weight, and no hypoglycemia or other adverse reactions were observed during use.
该中药配方治疗时临床观察:Clinical observations of the Chinese medicine formula in treatment:
(一)2型糖尿病诊断标准:诊断2型糖尿病(诊断标准参见《中国2型糖尿病防治指南(2017版)》);BMI≥24kg/m2。(I) Diagnostic criteria for type 2 diabetes: Diagnosis of type 2 diabetes (for diagnostic criteria, see the Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2017 Edition)); BMI ≥ 24 kg/m2.
(二)病例纳入标准(II) Case inclusion criteria
1.年龄18~65岁;1. Aged 18 to 65;
2.符合2型糖尿病标准;2. Meet the criteria for type 2 diabetes;
3.符合标准:BMI≥24kg/m2;3. Meet the criteria: BMI ≥ 24 kg/m2;
4.心肝肾功能正常;4. Normal heart, liver and kidney functions;
5.符合《赫尔辛基宣言》并签署知情同意书;5. Comply with the Declaration of Helsinki and sign the informed consent;
(三)病例排除标准(III) Case exclusion criteria
1.使用过胰岛素治疗者;1. Those who have used insulin therapy;
2.近期糖化血红蛋白≥12%;2. Recent glycosylated hemoglobin ≥ 12%;
3.妊娠、哺乳期妇女;3. Pregnant or lactating women;
4.恶性肿瘤或血液疾病;4. Malignant tumor or blood disease;
5.精神疾病;5. Mental illness;
6.严重胃出血的溃疡;6. Ulcers with severe gastric bleeding;
7.过度消瘦、营养不良;7. Excessive weight loss and malnutrition;
8.合并严重并发疾病;8. Patients with serious concurrent diseases;
9.3个月内使用药物或手术以减轻体质量者;9. Those who used drugs or surgery to lose weight within 3 months;
10.不能配合治疗、依从性差;10. Unable to cooperate with treatment and poor compliance;
11.研究者判断不适合入组的其他情况。11. Other situations that the researcher judges to be unsuitable for enrollment.
(四)治疗方法(IV) Treatment methods
所有患者在开始治疗前均签署知情同意书,适度饥饿的前一个月每天服用中药一剂,水煎两次,煎取汁液1000毫升左右,上午10-12点,下午3-6点期间,感到饥饿时就少量频繁饮用。All patients signed an informed consent form before starting treatment. In the first month of moderate hunger, they took one dose of Chinese medicine every day, decocted it in water twice, and extracted about 1000 ml of juice. They drank it in small amounts frequently when they felt hungry between 10-12 am and 3-6 pm.
(五)观察指标(V) Observation indicators
适度饥饿前、3个月、6个月的糖化血红蛋白等指标变化。Changes in indicators such as glycated hemoglobin before, 3 months, and 6 months of moderate starvation.
(六)结果禁食前后及随访糖化血红蛋白(%)比较(VI) Results Comparison of glycosylated hemoglobin (%) before and after fasting and during follow-up
临床上本发明药物用于34例2型糖尿病患者,均有效。The drug of the present invention was clinically used for 34 patients with type 2 diabetes and was effective.
(七)结论VII. Conclusion
本发明药物联合禁食对代谢综合征具有良好的治疗效果,且无明显不良反应;可以极大提高患者耐饥饿的能力和接受饮食控制的依从性。The drug of the present invention combined with fasting has a good therapeutic effect on metabolic syndrome without obvious adverse reactions; it can greatly improve the patient's ability to tolerate hunger and compliance with dietary control.
以上仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包括在本发明的保护范围之内。The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410249134.0A CN117883507A (en) | 2024-03-05 | 2024-03-05 | A Chinese medicine formula for indirectly reversing diabetes and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410249134.0A CN117883507A (en) | 2024-03-05 | 2024-03-05 | A Chinese medicine formula for indirectly reversing diabetes and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117883507A true CN117883507A (en) | 2024-04-16 |
Family
ID=90645086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410249134.0A Pending CN117883507A (en) | 2024-03-05 | 2024-03-05 | A Chinese medicine formula for indirectly reversing diabetes and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117883507A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111281914A (en) * | 2020-02-16 | 2020-06-16 | 丁虹 | Traditional Chinese medicine composition for treating pneumonia |
CN112957400A (en) * | 2021-02-06 | 2021-06-15 | 佛山市第五人民医院 | Research method of epimedium and morinda compound extracting solution |
-
2024
- 2024-03-05 CN CN202410249134.0A patent/CN117883507A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111281914A (en) * | 2020-02-16 | 2020-06-16 | 丁虹 | Traditional Chinese medicine composition for treating pneumonia |
CN112957400A (en) * | 2021-02-06 | 2021-06-15 | 佛山市第五人民医院 | Research method of epimedium and morinda compound extracting solution |
Non-Patent Citations (2)
Title |
---|
曾文红: "《家庭保健饮品》", vol. 1, 31 March 1995, 中国人口出版社, pages: 42 * |
范春光: "叉手自冒心", 《山东中医杂志》, no. 06, 27 December 1985 (1985-12-27), pages 46 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102028900B (en) | Traditional Chinese medicine for treating metabolic syndrome and preparation method thereof | |
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN103285119B (en) | A traditional Chinese medicine composition for treating autoimmune liver disease and its preparation method | |
CN106334060B (en) | A kind of pharmaceutical composition for treating obese polycystic ovary syndrome | |
CN106362104A (en) | Pharmaceutical composition for treating polycystic ovary syndrome in adolescence | |
CN108014267A (en) | A traditional Chinese medicine composition for improving immunity, lowering blood fat, protecting heart and brain and preparation method thereof | |
CN107281386B (en) | Method for preparing medicine for treating hypertension by using dendrobium officinale and radish seeds and application | |
CN117883507A (en) | A Chinese medicine formula for indirectly reversing diabetes and its preparation method | |
CN101327293B (en) | Capsule for treating peptic ulcer and preparation method thereof | |
CN100528186C (en) | Process for preparing Chinese medicine compound injection for treating chronic renal failure and use | |
CN103585206B (en) | A kind of preparation method of Chrysosplenium extract and application thereof | |
CN102283993B (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus | |
CN101653550A (en) | Chinese medicinal composition in preparation of medicament for treating type II diabetes | |
CN114796420B (en) | A traditional Chinese medicine composition for treating non-valvular atrial fibrillation and its preparation and application | |
CN103006868B (en) | A kind of traditional Chinese medicine composition for treating Behcet's disease | |
CN115192657B (en) | A kind of traditional Chinese medicine preparation and application thereof for treating type 2 diabetic nephropathy | |
CN114848775B (en) | A kind of traditional Chinese medicine composition for treating acute myocardial infarction and its traditional Chinese medicine preparation and application | |
CN103550290B (en) | Chinese medicinal composition for treating type 2 diabetes | |
CN100391484C (en) | Medicine for treating cardio-cerebrovascular disease | |
CN100534494C (en) | Panax ginseng dangshen composition and preparation method thereof | |
CN106619870A (en) | Composition for treating digestive system neoplasms, and preparation method of composition | |
CN108403803B (en) | A traditional Chinese medicine compound preparation for preventing and treating cardiovascular complications of diabetes | |
CN105943860A (en) | Medicine preparation for treating diabetes mellitus and preparation method thereof | |
CN120346261A (en) | Traditional Chinese medicine composition for treating hypertension and preparation method and application thereof | |
CN116492387A (en) | A kind of anti-hypoxia pharmaceutical composition and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |